Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: rTMS to Improve Cognition in Parkinson's [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating repetitive transcranial magnetic stimulation (rTMS) to improve cognition in Parkinson's disease with mild cognitive imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease, Mild Cognitive Impairment | Phase 1, Phase 2 | Status: RECRUITING